share_log

MasTec, Inc.'s (NYSE:MTZ) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

MasTec, Inc.'s (NYSE:MTZ) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

MasTec, Inc.(紐交所:MTZ)的股票正在上漲,但財務狀況看起來模糊:勢頭會持續嗎?
Simply Wall St ·  12/17 18:12

Most readers would already be aware that MasTec's (NYSE:MTZ) stock increased significantly by 20% over the past three months. But the company's key financial indicators appear to be differing across the board and that makes us question whether or not the company's current share price momentum can be maintained. Specifically, we decided to study MasTec's ROE in this article.

大多數讀者可能已經知道,MasTec(紐交所:MTZ)的股票在過去三個月內上漲了20%。但公司的主要財務指標似乎存在差異,這讓我們質疑公司當前的股價動能是否能夠持續。具體而言,我們決定在本文中研究MasTec的ROE。

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

股東權益回報率(ROE)是衡量公司價值增長和管理投資者資金有效性的一項指標。簡而言之,ROE展示了每一美元相對於股東投資所帶來的利潤。

How Is ROE Calculated?

淨資產收益率怎麼計算?

The formula for return on equity is:

股東權益回報率的公式是:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

股東權益回報率 = 凈利潤(來自持續運營)÷ 股東權益

So, based on the above formula, the ROE for MasTec is:

因此,根據上述公式,MasTec的ROE爲:

4.1% = US$116m ÷ US$2.8b (Based on the trailing twelve months to September 2024).

4.1% = 11600萬美元 ÷ 28億 (基於截至2024年9月的過去十二個月)。

The 'return' is the profit over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.04.

「回報」是過去十二個月的利潤。因此,這意味着每投資1美元,股東就能獲得0.04美元的利潤。

What Has ROE Got To Do With Earnings Growth?

ROE與盈利增長有何關係?

We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

我們已經確定,ROE可以作爲一種有效的衡量公司未來盈利能力的指標。現在我們需要評估公司再投資或「保留」的利潤有多少,這就給我們提供了有關公司增長潛力的想法。假設其他一切不變,ROE和利潤保留率越高,公司的增長率就越高,而不一定具備這些特徵的公司相比。

MasTec's Earnings Growth And 4.1% ROE

MasTec的盈餘增長和4.1%的ROE

It is quite clear that MasTec's ROE is rather low. Even when compared to the industry average of 16%, the ROE figure is pretty disappointing. Therefore, it might not be wrong to say that the five year net income decline of 48% seen by MasTec was possibly a result of it having a lower ROE. We reckon that there could also be other factors at play here. For example, the business has allocated capital poorly, or that the company has a very high payout ratio.

很明顯,MasTec的ROE相當低。即使與行業平均的16%相比,這個ROE數據也相當令人失望。因此,可以說MasTec五年內凈利潤下降48%可能是由於其較低的ROE所致。我們認爲這裏可能還有其他因素在起作用。例如,業務資本分配不當,或該公司有一個非常高的分紅派息比率。

So, as a next step, we compared MasTec's performance against the industry and were disappointed to discover that while the company has been shrinking its earnings, the industry has been growing its earnings at a rate of 16% over the last few years.

因此,作爲下一步,我們將MasTec的表現與行業進行了比較,令人失望的是,雖然該公司在縮減其盈餘,但行業在過去幾年中以16%的速度增長其盈餘。

big
NYSE:MTZ Past Earnings Growth December 17th 2024
紐交所:MTZ過去的盈餘增長 2024年12月17日

Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. What is MTZ worth today? The intrinsic value infographic in our free research report helps visualize whether MTZ is currently mispriced by the market.

盈利增長是評價股票時需要考慮的重要指標。投資者應該嘗試判斷預期的盈利增長或下降,無論是哪種情況,是否已經反映在股價中。這將幫助他們判斷該股票的未來是光明還是黯淡。那麼,MTZ今天值多少錢?我們免費研究報告中的內在價值信息圖幫助可視化MTZ是否被市場低估。

Is MasTec Making Efficient Use Of Its Profits?

MasTec是否充分利用其利潤?

Because MasTec doesn't pay any regular dividends, we infer that it is retaining all of its profits, which is rather perplexing when you consider the fact that there is no earnings growth to show for it. So there could be some other explanations in that regard. For instance, the company's business may be deteriorating.

由於MasTec不支付任何定期分紅,我們推測它正在保留所有利潤,這讓人感到困惑,因爲沒有盈利增長可供展示。因此可能還有其他解釋。例如,公司的業務可能正在惡化。

Summary

總結

In total, we're a bit ambivalent about MasTec's performance. While the company does have a high rate of profit retention, its low rate of return is probably hampering its earnings growth. That being so, the latest industry analyst forecasts show that the analysts are expecting to see a huge improvement in the company's earnings growth rate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

總的來說,我們對MasTec的表現有些模棱兩可。雖然該公司確實有較高的利潤保留率,但其較低的回報率可能妨礙了其盈利增長。儘管如此,最新的行業分析師預測顯示,分析師們預計公司盈利增長率將大幅改善。有關公司未來盈利增長預測的更多信息,請查看此份關於公司分析師預測的免費報告,以獲取更多信息。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論